Intravenous colistin use for infections due to multidrug-resistant gram-negative bacilli in critically ill paediatric patients: a systematic review and meta-analysis
S. A. Karageorgos, H. Bassiri, G. Siakallis, M. Miligkos, C. Tsioutis
This study evaluates the clinical effectiveness and safety of intravenous colistin for treating multidrug-resistant gram-negative bacilli infections in critically ill pediatric patients, finding notable mortality rates and potential dosing issues.
bioRxiv · Nov 8, 2018Microbiology